InterWest

InterWest Partners is a California-based venture capital firm established in 1979, specializing in investments in the healthcare and information technology sectors across North America. The firm typically invests between $7 million and $15 million in its portfolio companies, participating in various stages of venture financing. While InterWest generally focuses on early-stage companies, it also considers opportunities based on their individual merits, regardless of the investment stage. This flexible investment approach allows InterWest to engage with a diverse range of companies, supporting their growth and development over multiple rounds of financing.

Farah Champsi

Managing Partner

Keval Desai

General Partner

Doug Fisher

Executive in Residence

Flip Gianos

General Partner Emeritus

W. Stephen Holmes

General Partner Emeritus

Gil Kliman

Managing Partner

Gilbert Kliman

Managing Partner

Khaled Nasr

General Partner and COO

Arnie Oronsky

Managing Partner

Arnold L. Oronsky

Managing Partner

Michelle Snyder

Advisor

Karen Wilson

CFO

Reza Zadno

Advisor

435 past transactions

Staccato Communications

Series B in 2004
Staccato Communications, Inc. offers ultra wideband wireless enabled devices for the wireless USB, Bluetooth, and Internet protocol connectivity to the personal computing, consumer electronics, and mobile phone industries. Its products include single-chip integrated circuits, device adapter and device module design kits, reference design kits, wireless USB development kits, and streaming services development kits. The company also provides Ripcord Software, which provides a software stack for variety of ultra wide band applications, as well as includes installers, firmware, middleware, drivers, customization tools, and firmware upgrade tools. Staccato Communications’ products are used in various applications, such as printers, camera, mass storage devices, portable media players, wireless docking, wireless projectors, Web cameras, wireless HDTV, wireless speakers, set top boxes, wireless displays, purchasing content, sharing content, and personal servers. Staccato Communications, Inc. was formerly known as Discrete Time Communications, Inc. The company was founded in 2002 and is based in San Diego, California.

The RealReal

Series D in 2015
The RealReal, Inc. operates an online marketplace for consigned luxury goods. It offers various resale product categories, including women’s, men’s, kids’, jewelry, and watches, as well as home and art products. The company was founded in 2011 and is headquartered in San Francisco, California.

ReVision Optics

Series D in 2010
ReVision Optics, Inc. designs, manufactures, and delivers implantable products for the treatment of presbyopia. It offers PRESBYLENS Corneal Inlay, a refractive surgery solution to correct vision lost by the natural aging process called presbyopia. The company serves the ophthalmology professionals. ReVision Optics, Inc. was formerly known as IntraLens Vision, Inc. and changed its name to ReVision Optics, Inc. in 2005. The company was founded in 1996 and is based in Lake Forest, California.

Badgeville

Series C in 2012
Badgeville is the leading business gamification company with hundreds of global brand customers. With its unique combination of in-app gamification, SaaS platform and big data analytics, Badgeville is building the future of work. The company was founded in 2010 and is headquartered in Silicon Valley. Based in Redwood, CA, the Badgeville team includes experts from Zynga, Playdom, Omniture, Google, Salesforce.com, Amazon, WebEx, Microsoft and more. Badgeville investors are InterWest Partners, Norwest Venture Partners, Trinity Ventures and El Dorado Ventures. To learn more, follow @Badgeville or visit www.badgeville.com.

TESARO

Series B in 2011
Founded in 2010, TESARO is a privately held oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. The Company intends to leverage the experience and competencies of its management team to identify, acquire and develop promising drug candidates; and to commercialize safer and more effective products for the treatment and support of cancer patients. TESARO is developing rolapitant, a potent, selective neurokinin-1 receptor antagonist that has completed Phase 2 clinical testing for the prevention of chemotherapy induced nausea and vomiting, and is advancing its ALK inhibitor program for oncology indications. Phase 3 clinical testing of rolapitant is planned to commence during 2011 and the first ALK inhibitor clinical trial is targeted to begin in 2012. TESARO was co-founded by former executives of MGI PHARMA, an oncology and acute-care focused biopharmaceutical company that Eisai Co., Ltd. acquired in 2008 for $3.9 billion. TESARO is headquartered in Waltham, Massachusetts.

Participate Systems

Series D in 2002
Participate Systems provides outsourced online sales and customer support community solutions. The platform offers self-help solutions, software and management services, monthly and quarterly reports, and operating plans.

Drais Pharmaceuticals

Series A in 2012
Drais Pharmaceuticals, Inc. is a venture capital supported drug development company with an exciting new business model. Through strong relationships with Astellas Pharma Inc. and our venture capital investors - InterWest Partners, Sutter Hill Ventures, and Astellas Venture Management LLC, we have created multiple virtual companies to enable the development of interesting novel compounds in a variety of therapeutic areas. Our focus is on early stage development through proof of concept. Our business model relies on a small internal team who provide drug development services to those virtual companies via vendors and CROs. Our internal experts are able to move compounds rapidly through key development milestones and decision points, thus de-risking programs early in development.

Dynavax Technologies

Series D in 2002
Dynavax Technologies Corporation is a clinical-stage biopharmaceutical company committed to discovering and developing novel products to prevent and treat infectious diseases.
PrimeraDx, Inc. offers multiplexed infectious disease assays. It provides Scalable Target Amplification Routine technology, which is a method for simultaneous quantitative measurement of multiple target nucleic acids. The company also offers ViraQuant, a multiplexed assay providing quantitative and simultaneous measurement of viruses; and FungiQuant Yeast and FungiQuant Mold, which are fungal panels for mycology testing. Its products are used in miRNA, DNA methylation, quantitative genotyping, gene expression, and viral load measurement applications. PrimeraDx, Inc. was founded in 2004 and is based in Mansfield, Massachusetts.

Virsto Software

Series B in 2011
Virsto was founded in late 2007 by a team of storage and virtualization experts who saw that the old ways of doing storage were not working in the virtual server era. We believe we are building a visionary storage software platform that will fundamentally transform the data center – decoupling storage from the physical world once and for all to save organizations time and money. Virsto's solutions address the growing need for cost-effective and efficient storage for virtual servers and desktops. Companies around the world use Virsto to achieve increases in performance, reduce storage capital and operating costs, and streamline provisioning and data management for virtual computing.

Damballa

Series E in 2014
As the experts in advanced threat protection, Damballa discovers active threats that bypass all security prevention layers. Damballa automatically identifies successful infections and pinpoints devices that represent the highest risk to a business. Our patent-pending solutions combine principles of data science and machine learning to discover threats without prior knowledge of them and regardless of device type, OS and threat vector. Damballa protects nearly a billion endpoints globally at enterprises in every major market and for the world’s largest ISP and telecommunications providers. For more information, visit www.damballa.com, or follow us on Twitter @DamballaInc. Watch an analyst interview with Brian Foster, CTO until June, 2015 , here: https://vimeo.com/129326008

Labrys Biologics

Series A in 2013
Labrys Biologics Inc., a company focused on treatments for chronic migraine. Labrys Biologics has acquired worldwide rights to RN-307 from Pfizer Inc. RN-307 is an antibody for the treatment of chronic migraine.

GAIN Fitness

Seed Round in 2011
GAIN Fitness's web and mobile applications generate personalized training plans based on exercise science, matched to an individual's body, goals, and lifestyle factors, to help regular exercisers optimize fitness and adapt to schedule changes. They motivate exercisers with social tie-ins and game mechanics, and keep things fresh with their custom built database of over 750 exercises. They're partnering with personal trainers and equipment retailers to sell interactive multimedia packs, a la App Store for Fitness.

InVisage Technologies

Series E in 2014
InVisage Technologies Inc., a fabless semiconductor company, produces quantum dot-based image sensors. The company's product enables the high resolution images from handheld devices, such as camera phones and PDAs. Its products are used in security and surveillance, automotive imaging, military, and medical imaging applications, as well as mobile phone cameras, Webcams, and digital still cameras. The company was incorporated in 2005 and is based in Menlo Park, California.

Flurry

Series D in 2013
Flurry is an application that provides analytics for businesses to monitor the trends and habits of mobile users across multiple mobile applications. Flurry’s mobile analytics solution enables businesses to understand how consumers interact with their mobile applications. Over 125,000 companies use Flurry’s analytics platform in more than 400,000 applications to measure audience reach, engagement, retention, conversions, revenue, and more. The service is completely free, takes just five minutes for basic integration, and is continuously updated with the industry's advanced features. Flurry Analytics is available for iOS, Android, Windows Phone, HTML5, hybrid apps, mobile/web, Blackberry, and JavaME.

Carwoo

Series A in 2010
Carwoo is an online platform that enables its users to anonymously buy cars from dealers in their local area. Carwoo was launched in 2008 and is based in California.

Bivio Networks

Venture Round in 2008
Founded in 2000, Bivio Networks is dedicated to providing leading networking products that enable government agencies and service providers to control, monitor, and secure critical network infrastructure. A leader in cyber intelligence, cyber security and network control solutions, Bivio has deployed its products in a wide range of solutions. Bivio’s global customer base includes leading intelligence agencies, military organizations and service providers. Bivio is privately-held and is headquartered in the San Francisco Bay Area with office locations worldwide. Specialties Cyber Security, Cyber Intelligence, Deep Packet Inspection (DPI) Networking Systems, Mass Metadata Extraction and Analysis, Data Retention System, Cyber Investigation, network probe

Ophthonix

Series C in 2005
Ophthonix, Inc. manufactures and markets high resolution spectacle lenses for vision assessment and correction applications. It offers its high resolution lenses for single vision spectacle lenses for the correction of myopia, hyperopia, and mild astigmatism; and progressive addition spectacle lenses. The company sells its products through practitioners in the United States and European countries. Ophthonix, Inc. was founded in 2000 and is based in Vista, California.

InVisage Technologies

Series D in 2013
InVisage Technologies Inc., a fabless semiconductor company, produces quantum dot-based image sensors. The company's product enables the high resolution images from handheld devices, such as camera phones and PDAs. Its products are used in security and surveillance, automotive imaging, military, and medical imaging applications, as well as mobile phone cameras, Webcams, and digital still cameras. The company was incorporated in 2005 and is based in Menlo Park, California.

Anesiva

Series C in 2002
Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for pain management worldwide. Its lead product candidate includes Adlea, which completed multiple Phase II and Phase III trials for post-surgical, musculoskeletal, and neuropathic pain. The company was formerly known as AlgoRx Pharmaceuticals, Inc., it changed its name to Anesiva, Inc. in 2006. Anesiva, Inc. was founded in 1999 and is headquartered in South San Francisco, California. On January 15, 2010, Anesiva, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of California. On June 10, 2014 filed for Chapter 7 bankruptcy.

AppMesh

Series A in 2013
AppMesh is building the next generation business platform for mobile devices. Founded by salesforce.com veterans, we believe that in the post-PC era business applications need to be personal, seamless, and intuitive.

ReVision Optics

Series C in 2004
ReVision Optics, Inc. designs, manufactures, and delivers implantable products for the treatment of presbyopia. It offers PRESBYLENS Corneal Inlay, a refractive surgery solution to correct vision lost by the natural aging process called presbyopia. The company serves the ophthalmology professionals. ReVision Optics, Inc. was formerly known as IntraLens Vision, Inc. and changed its name to ReVision Optics, Inc. in 2005. The company was founded in 1996 and is based in Lake Forest, California.

Open Silicon

Series D in 2007
Open-Silicon provides leading edge SoC and Custom IC design, open market IP integration, and high-quality silicon manufacturing services to customers worldwide. As a fabless company, Open-Silicon focuses on delivering the most cost-effective, predictable and reliable custom SoC solutions. The company partner with customers using flexible models that sometimes include full turnkey development from spec handoffs, and sometimes include only manufacturing services to take advantage of volume foundry, test, and packaging pricing. Since its founding in 2003, the company has focused on raising the bar on SoC execution, measuring the quality of engineering work and ability to hit customer schedules and reporting that to the board of directors at every board meeting.

Restoration Robotics

Venture Round in 2016
Restoration Robotics is a privately held medical device company, is dedicated to revolutionizing the field of hair transplantation by developing and commercializing a state-of-the-art image-guided system (ARTAS™ System) that enables follicular unit extraction.

Nereus Pharmaceuticals

Series D in 2005
Nereus Pharmaceuticals, Inc. engages in the discovery and development of therapeutics for the treatment of oncology, infectious diseases, and inflammation. The company uses its marine microbiology technologies for the discovery and development of drug candidates. Its oncology drug candidates include NPI-2358, a tumor vascular disrupting agent for the treatment of solid tumors; and NPI-0052, a proteasome inhibitor for the treatment of solid tumors, lymphomas, and multiple myeloma. The company was founded in 1998 and is based in San Diego, California.

Brecis Communications

Series C in 2003
BRECIS Communications, a communications company focused on leading-edge, broadband multi-service network processor architectures.

APT Pharmaceuticals

Series B in 2008
APT Pharmaceuticals is a drug development company focused on repurposing well-characterized drugs for under-served populations. APT’s initial focus is on the pulmonary delivery of treatments for serious lung diseases.

The RealReal

Series B in 2013
The RealReal, Inc. operates an online marketplace for consigned luxury goods. It offers various resale product categories, including women’s, men’s, kids’, jewelry, and watches, as well as home and art products. The company was founded in 2011 and is headquartered in San Francisco, California.

Voyence

Venture Round in 2004
Voyence provides configuration and change management solutions that automate critical change, compliance, and activation processes. The company offers VoyenceControl NG solution, which manages various devices in a heterogeneous infrastructure; automates configuration management lifecycle, including design, change, and compliance; and collects data in its repository, including configuration, asset/hardware, and change and audit information. It offers compliance/security, change/configuration, and extending network management solutions. The company's customers include financial, healthcare, education, government, manufacturing, services, technology, and transportation organizations. Voyence, Inc. was founded in 2000 as PowerUp Networks and it changed its name to Voyence, Inc. in 2003. The company is headquartered in Richardson, Texas.

Welltok

Series D in 2015
Welltok is a data-driven, enterprise SaaS company that delivers the healthcare industry’s leading consumer activation platform. Welltok’s solutions empower health plans, employers, providers, and public entities to connect consumers with personalized health improvement resources, making it easy and rewarding for consumers to complete actions that optimize their health and wellbeing. The company was founded in 2009 and headquartered in Denver, Colorado.

C9 Inc.

Series B in 2009
C9 delivers predictive sales and marketing applications that increase revenue, generate more precise forecasts and mitigate pipeline risk. By combining data science with products that improve sales and marketing execution, C9 enables leading companies like Yahoo!, Pitney Bowes and Google to drive predictable growth. C9 is located in San Mateo and is backed by the Mayfield Fund, InterWest Partners and Leapfrog Ventures.

Brand.net

Series B in 2008
Brand.net is an online advertising network focused exclusively on brand advertising. Their technology is designed to allow Brand advertisers and agencies to reach the right target in the right context, efficiently and measurably.

Damballa

Series D in 2011
As the experts in advanced threat protection, Damballa discovers active threats that bypass all security prevention layers. Damballa automatically identifies successful infections and pinpoints devices that represent the highest risk to a business. Our patent-pending solutions combine principles of data science and machine learning to discover threats without prior knowledge of them and regardless of device type, OS and threat vector. Damballa protects nearly a billion endpoints globally at enterprises in every major market and for the world’s largest ISP and telecommunications providers. For more information, visit www.damballa.com, or follow us on Twitter @DamballaInc. Watch an analyst interview with Brian Foster, CTO until June, 2015 , here: https://vimeo.com/129326008

Achates Power

Series A in 2009
Achates Power specializes in the fields of combustion engine development, clean diesel, and 2-stroke oil control management. The company is on a mission to build better, more efficient engines, the company has an experienced staff of engineers and scientists focused on applying their proven technical know-how and expertise, coupled with the industry's leading-edge testing, simulation, and analysis tools. it was founded in 2004 and headquartered in San Diego, California.

Totango

Series D in 2018
Totango, Inc. develops an enterprise grade customer success platform that allows users to connect their customers’ data, monitor health changes, and engage their customers. The company offers Customer Success Centre, a solution for customer engagement; Zoe, a solution for enterprise impact; and DNA-CX, a solution for multidimensional customer context in real-time. Its solutions include voice of the customer, customer onboarding, customer adoption, customer renewal, and customer escalation. The company was founded in 2010 and is based in Redwood City, California. Totango, Inc. operates as a subsidiary of Totango Ltd.

Spredfast

Series F in 2016
Spredfast, Inc. provides a social relationship platform that allows enterprise brands and organizations to manage, monitor, and measure their social media programs in the United States and internationally. The company was formerly known as Social Agency, Inc. and changed its name to Spredfast, Inc. in January 2010. Spredfast, Inc. was founded in 2008 and is based in Austin, Texas with an additional office in London, United Kingdom. As of October 2, 2018, Spredfast, Inc. operates as a subsidiary of Lithium Technologies Inc.

Centrexion Therapeutics

Series C in 2016
Centrexion Therapeutics is focused on developing new therapies for moderate to severe chronic pain that address the safety and efficacy gaps in the current treatment paradigm.We aim to relieve the suffering associated with chronic pain by creating treatments that address the safety and efficacy gaps in the current treatment paradigm.

Nuventix

Venture Round in 2011
Nuventix is an active thermal management solutions company located in Austin, Texas. The Nuventix-developed SynJet® module is a newly patented synthetic jet cooling technology that utilizes turbulent pulses of air generated from an electromagnetic actuator. Based on early success with computer cooling, Nuventix's innovative approach to LED cooling is propelling that market forward two years ahead of analyst estimates - truly affecting the industry and allowing general illumination designs to harvest the efficiencies of the LED.
Advanced Micro-Fabrication Equipment Inc. (中微半导体设备(上海)有限公司) is a Chinese global microfabrication equipment company serving customers in the semiconductor industry and relevant high-tech sectors. The company is a specialized supplier of key equipment for the production and development of micron-sized and nanoscale VLSI for the semiconductor industry in China and Asia. The company is focused on chemical vapor deposition and plasma etching products.

MacroGenics

Series A in 2001
MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases. The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology. The company was founded in 2000 and is headquartered in Rockville, Maryland.

LongBoard

Series C in 2002
LongBoard, Inc. provides software solutions to enable the telecommunications carriers and service providers to deliver converged multimedia services. Its products include MediaRoam that provides telecommunications carriers with the ability to deliver differentiated Initiation Protocol Multimedia Subsystem enabled multimedia services across fixed and mobile networks; LongBoard Multimedia Application Platform, which provides a carrier-class software infrastructure for integrating IP-based communications; and OnePhone, a personal mobility application that automatically and transparently switches calls between cellular and WiFi networks. LongBoard, Inc. was formerly known as Persona Software, Inc. and it changed its name to LongBoard, Inc. in February 2006. The company was founded in 1999 and is based in Santa Clara, California with sales offices in London, the United Kingdom and Tokyo, Japan.

CardioMind

Series B in 2004
CardioMind, Inc. Inc manufactures therapeutic devices for cardiovascular diseases. The company also offers stent delivery systems, which are designed for use in lesion applications, as well as for the treatment of coronary and peripheral artery diseases. In addition, it provides invasive endovascular medical devices for treating neurological and cardiovascular diseases. The company was founded in 2003 and is based in Sunnyvale, California.

Epocrates

Series B in 2000
Epocrates develops mobile and online clinical information and decision support software that enables health-care professionals to find answers more quickly and confidently at the point of care. 1 out of 3 U.S. physicians and 1 out of 3 U.S. medical students currently use Epocrates software.

Wiser Solutions

Venture Round in 2016
Wiser is the leading provider of actionable data for better decisions. Wiser collects and analyzes online and in-store data with unmatched speed, scale and accuracy. The Wiser platform then blends these insights with advanced workflow software to drive business value for brands and retailers. Using a unique combination of data science and human validation, Wiser offers integrated solutions for every aspect of retail, all in one place.

Brand.net

Series A in 2007
Brand.net is an online advertising network focused exclusively on brand advertising. Their technology is designed to allow Brand advertisers and agencies to reach the right target in the right context, efficiently and measurably.

SpectraLinear

Series A in 2006
SpectraLinear, Inc., a fabless mixed signal IC company, designs, develops, manufactures, and markets timing circuits. The company's products include computer clocks, buffers, zero delay buffers, EMI reduction circuits, and systems clocks for the consumer and PC clock applications. Its products enable various electronic applications, such as digital television, high definition digital television, digital still camera, digital movie camera or camcorders, set-top box, multi function printers, laser and inkjet printers, copiers, notebook and desktop computers, servers, and communication systems, as well as automotive, gaming, cash registers, and other industrial applications. The company serves consumer, computer, and communication markets. It has locations in Istanbul, Turkey; Bangalore, India; Taiwan; and Japan. SpectraLinear, Inc. was founded in 2006 and is based in Santa Clara, California.

Ribbon

Pre Seed Round in 2011
Ribbon Payments, Inc. operates a platform that allows users to sell and purchase products by sharing a unique showcase link. The company supports various types of products from physical and digital goods to services, such as T-shirts, mp3s, and tutoring products. It process debit and credit cards for payments. Ribbon Payments, Inc. was formerly known as Kout Inc. and changed its name to Ribbon Payments, Inc. in November 2012. The company was incorporated in 2011 and is based in San Francisco, California.

Trius Therapeutics

Series A in 2007
Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. We have successfully completed two Phase 3 clinical trials for Tedizolid Phosphate (TR-701), formerly torezolid phosphate, in ABSSSI. Tedizolid is an IV and orally administered second generation oxazolidinone, for the treatment of serious gram-positive bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA). With the continuous increase in bacterial resistance to currently marketed drugs, serious infections are becoming more difficult, if not impossible to treat, and this has led to a clear need for novel therapeutics to treat multi-drug resistant bacterial infections. Trius is headquartered in San Diego, California. We have built a strong management team with significant development and regulatory experience. Our senior management team consists of nine individuals who collectively have been involved in the development and approval of a significant number of anti-infective drugs.

Neuronetics

Series B in 2005
Neuronetics is focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. The company was founded in 2003 and is based in Malvern, Pennsylvania.

Neuronetics

Series A in 2003
Neuronetics is focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. The company was founded in 2003 and is based in Malvern, Pennsylvania.

QuatRx Pharmaceuticals

Series C in 2003
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics. Its products include Osphena for the treatment for vaginal atrophy, a common problem associated with estrogen deficiency in post-menopausal women. QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan.

Braze

Series D in 2017
Braze is a comprehensive customer engagement platform that powers relevant and memorable experiences between consumers and the brands they love. Context underpins every Braze interaction, helping brands foster human connection with consumers through interactive conversations across channels that deliver value quickly and continuously. The company was named a Leader in the 2019 Gartner Magic Quadrant for Mobile Marketing Platforms and was recognized as one of Inc Magazine's 2019 Best Workplaces. Braze is headquartered in New York with offices in Chicago, London, San Francisco, and Singapore. Learn more at braze.com.

TESARO

Post in 2016
Founded in 2010, TESARO is a privately held oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. The Company intends to leverage the experience and competencies of its management team to identify, acquire and develop promising drug candidates; and to commercialize safer and more effective products for the treatment and support of cancer patients. TESARO is developing rolapitant, a potent, selective neurokinin-1 receptor antagonist that has completed Phase 2 clinical testing for the prevention of chemotherapy induced nausea and vomiting, and is advancing its ALK inhibitor program for oncology indications. Phase 3 clinical testing of rolapitant is planned to commence during 2011 and the first ALK inhibitor clinical trial is targeted to begin in 2012. TESARO was co-founded by former executives of MGI PHARMA, an oncology and acute-care focused biopharmaceutical company that Eisai Co., Ltd. acquired in 2008 for $3.9 billion. TESARO is headquartered in Waltham, Massachusetts.

Covaro Networks

Series A in 2002
Covaro Networks develops telecommunications products for converged networks, enabling network infrastructure providers to unlock stranded profits while using high bandwidth services and containing capital and operating expenditures.

Centrexion Therapeutics

Private Placement in 2017
Centrexion Therapeutics is focused on developing new therapies for moderate to severe chronic pain that address the safety and efficacy gaps in the current treatment paradigm.We aim to relieve the suffering associated with chronic pain by creating treatments that address the safety and efficacy gaps in the current treatment paradigm.

Pivot3

Venture Round in 2013
Global Hyper-Converged Infrastructure

Pivot3

Series C in 2008
Global Hyper-Converged Infrastructure
Aspreva Pharmaceuticals Corp is an emerging pharmaceutical company headquartered in Victoria, British Columbia focused on identifying, developing and commercializing new indications for approved drugs and drug candidates for underserved patient populations. Their strategy, which they call “indication partnering”, is to collaborate with pharmaceutical and biopharmaceutical companies to pursue new indication approvals which lie beyond their strategic focus.

QuatRx Pharmaceuticals

Series E in 2007
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics. Its products include Osphena for the treatment for vaginal atrophy, a common problem associated with estrogen deficiency in post-menopausal women. QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan.

Spredfast

Series B in 2011
Spredfast, Inc. provides a social relationship platform that allows enterprise brands and organizations to manage, monitor, and measure their social media programs in the United States and internationally. The company was formerly known as Social Agency, Inc. and changed its name to Spredfast, Inc. in January 2010. Spredfast, Inc. was founded in 2008 and is based in Austin, Texas with an additional office in London, United Kingdom. As of October 2, 2018, Spredfast, Inc. operates as a subsidiary of Lithium Technologies Inc.

Ample Communications

Series C in 2004
As of September 25, 2007, Ample Communications, Inc. was acquired by Mindspeed Technologies, Inc. Ample Communications, Inc. develops silicon solutions for optimizing networking infrastructure. The company provides Ethernet MACs for increasing the performance of enterprise and wide-area networks. It offers integrated MACs that optimize Ethernet aggregation, as well as Gigabit Ethernet silicon solutions for the PC market. The company provides its products for various applications, including Ethernet switches and routers, Internet appliances, access devices in enterprise and metro applications, IPTV equipment, metro Ethernet, wireless/cellular backhaul, and Ethernet over SONET applications. Ample Communications, Inc. was founded in 2000 and is headquartered in Fremont, California.

Restoration Robotics

Venture Round in 2016
Restoration Robotics is a privately held medical device company, is dedicated to revolutionizing the field of hair transplantation by developing and commercializing a state-of-the-art image-guided system (ARTAS™ System) that enables follicular unit extraction.

Open Silicon

Series C in 2005
Open-Silicon provides leading edge SoC and Custom IC design, open market IP integration, and high-quality silicon manufacturing services to customers worldwide. As a fabless company, Open-Silicon focuses on delivering the most cost-effective, predictable and reliable custom SoC solutions. The company partner with customers using flexible models that sometimes include full turnkey development from spec handoffs, and sometimes include only manufacturing services to take advantage of volume foundry, test, and packaging pricing. Since its founding in 2003, the company has focused on raising the bar on SoC execution, measuring the quality of engineering work and ability to hit customer schedules and reporting that to the board of directors at every board meeting.

NovaCardia

Series B in 2007
NovaCardia is a product-focused pharmaceutical company with significant capabilities and experience in cardiovascular drug development. The company is committed to improving the quality of care for patients with cardiovascular disease by developing and commercializing a portfolio of novel small molecule drugs. NovaCardia will be focused initially on the acute cardiac care marketplace.
PMV Pharmaceuticals, Inc., a precision oncology company, discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. Its lead product candidate is PC14586, a small molecule that corrects and restores p53 function. The company also develops product candidates for p53 R273H hotspot mutation and other p53 hotspot mutations. PMV Pharmaceuticals, Inc. was formerly known as PJ Pharmaceuticals, Inc. and changed to in July 2013. The company was founded in 2013 and is headquartered in Cranbury, New Jersey.

CardioMind

Venture Round in 2008
CardioMind, Inc. Inc manufactures therapeutic devices for cardiovascular diseases. The company also offers stent delivery systems, which are designed for use in lesion applications, as well as for the treatment of coronary and peripheral artery diseases. In addition, it provides invasive endovascular medical devices for treating neurological and cardiovascular diseases. The company was founded in 2003 and is based in Sunnyvale, California.

Flurry

Series B in 2010
Flurry is an application that provides analytics for businesses to monitor the trends and habits of mobile users across multiple mobile applications. Flurry’s mobile analytics solution enables businesses to understand how consumers interact with their mobile applications. Over 125,000 companies use Flurry’s analytics platform in more than 400,000 applications to measure audience reach, engagement, retention, conversions, revenue, and more. The service is completely free, takes just five minutes for basic integration, and is continuously updated with the industry's advanced features. Flurry Analytics is available for iOS, Android, Windows Phone, HTML5, hybrid apps, mobile/web, Blackberry, and JavaME.

Sera Prognostics

Series A in 2011
Sera Prognostics, Inc., a biotechnology company, develops diagnostic tests for the early prediction of a woman’s individualized risk of premature birth, preeclampsia, and other pregnancy complications. It focuses on addressing the economic and healthcare burden that premature birth places on infants, their families, and society. Sera Prognostics, Inc. was founded in 2008 and is based in Salt Lake City, Utah.

CVRx

Series D in 2007
CVRx is a medical device company that develops implantable technology for the treatment of high blood pressure. Its products include Rheos implantable pulse generator that provides control and delivery of the activation energy; and Rheos carotid sinus leads, which conducts activation energy from the Rheos implantable pulse generator to the left and right carotid arteries. The company also offers a Rheos programmer system that communicates with the Rheos pulse generator. CVRx was founded in 2001 and is based in Minneapolis, Minnesota.

AkaRx

Series A in 2005
AkaRx, Inc., a biopharmaceutical company, develops therapeutic treatments for unmet medical needs. Its product includes AKR-501, an orally-available small molecule for use in the treatment of thrombocytopenia. The company was founded in 2005 and is headquartered in Paramus, New Jersey.

Corixa

Series A in 1995
Corixa is a developer of immunotherapeutics with a commitment to treating and preventing autoimmune diseases, cancer and infectious diseases by understanding and directing the immune system. Having founded in 1994, the company conducted various preclinical development programs, including the BEXXAR® therapy and the MELACINE® vaccine. Corixa is focused on immunotherapeutic products and has a broad technology platform enabling both fully integrated vaccine design and the use of its separate, proprietary product components on a standalone basis. The company partners with numerous developers and marketers of pharmaceuticals, targeting products that are powered by Corixa™ technology with the goal of making its potential products available to patients around the world. Corixa was acquired by GlaxoSmithKline on 12 July 2005, and GSK had formerly made use of the Corixa's MPL adjuvant in some of their vaccines. The company ceased operations in March 2006.

Aryaka

Series C in 2014
[Aryaka](http://www.aryaka.com)'s Global SD-WAN provides optimized, software-defined network connectivity and application acceleration to globally distributed enterprises. Aryaka’s services have over 10 million users across more than 4,000 sites. Leading brands such as Skullcandy, Air China, Freescale Semiconductor, and ThoughtWorks, as well as partners such as Microsoft Azure, AWS, Intelisys, and SK Broadband, have all chosen Aryaka for their enterprise-grade networking needs.

Achates Power

Series D in 2017
Achates Power specializes in the fields of combustion engine development, clean diesel, and 2-stroke oil control management. The company is on a mission to build better, more efficient engines, the company has an experienced staff of engineers and scientists focused on applying their proven technical know-how and expertise, coupled with the industry's leading-edge testing, simulation, and analysis tools. it was founded in 2004 and headquartered in San Diego, California.

Kajeet

Series B in 2007
Kajeet, the industry leader for safe, mobile student Internet connectivity, is closing the Homework Gap in school districts across the country. Kajeet provides an affordable mobile broadband solution that connects low-income students to the resources needed to complete homework. The Kajeet SmartSpot® (a portable Wi-Fi hotspot), and the Kajeet SmartBus™ (school bus Wi-Fi) solutions combined with the innovative Sentinel® cloud portal, enables administrators and teachers to provide CIPA-compliant, customizable filtered Internet access that keeps students focused on school work and provides mobile Internet connectivity for education without worry of data abuse.

Silicon Optix

Series C in 2004
Silicon Optix is a fabless semiconductor company, supplier of warping integrated circuit (IC) technology – eWARP™. eWARP digital distortion correction allows manufacturers to complement optics with sophisticated electronics imaging in order to achieve superior system designs and add new compelling features to products while reducing cost and complexity of optical systems. Silicon Optix has the only mainstream geometry processing IC in volume production to date. Over seven years of research and development invested in IC design, system design and optics have given Silicon Optix the expertise to be the leader in this emerging technology with large market opportunities.

Chiaro Networks

Series C in 2000
Chiaro Networks, Inc. engages in the design, manufacture, and delivery of Internet protocol/multi protocol label switching in the United States.

Gynesonics

Debt Financing in 2014
Gynesonics, Inc. designs and develops minimally invasive solutions for symptomatic uterine fibroids in women. The company offers Sonography-Guided Transcervical Fibroid Ablation (Sonata) System(The Sonata System) for the transcervical treatment of symptomatic uterine fibroids under intrauterine sonography guidance serving customers in the European Union. Gynesonics, Inc. was founded in 2005 and is based in Redwood City, California with an additional location in Beuningen, the Netherlands.

Fluidigm

Venture Round in 2009
Fluidigm Corporation develops and distributes systems based on the properties of integrated fluidic circuits to control precisely fluids on a nano volume scale. The company's product line includes the TOPAZ system, which is used for protein crystallization; and the BioMark system, which is used for genetic analysis. Fluidigm Corporation was founded as Mycometrix Corporation in 1999 and was renamed as Fluidigm Corporation in 2001. The company is based in San Francisco, California.

Intarcia Therapeutics

Series E in 2004
Intarcia Therapeutics is a biopharmaceutical company that develops therapies for diseases that require long-term chronic treatment. It offers DUROS, a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides. Intarcia Therapeutics' products include OMEGA DUROS, an interferon delivery device for treating Hepatitis C and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity. David Franklin, James M. Ahlers, and Thomas Alessi founded BioMedicines in 1997 that became Intarcia Therapeutics in September 2004. Its headquarters is in Hayward in California with an additional office in Mountain View in California.
PrimeraDx, Inc. offers multiplexed infectious disease assays. It provides Scalable Target Amplification Routine technology, which is a method for simultaneous quantitative measurement of multiple target nucleic acids. The company also offers ViraQuant, a multiplexed assay providing quantitative and simultaneous measurement of viruses; and FungiQuant Yeast and FungiQuant Mold, which are fungal panels for mycology testing. Its products are used in miRNA, DNA methylation, quantitative genotyping, gene expression, and viral load measurement applications. PrimeraDx, Inc. was founded in 2004 and is based in Mansfield, Massachusetts.

Victorious

Series A in 2014
Victorious empowers creators to distribute all of their multimedia content in their own apps, interact more deeply and directly with their fan communities, and unlock new revenue streams. The company was founded in 2013 and is based in Santa Monica, California.

The RealReal

Series C in 2014
The RealReal, Inc. operates an online marketplace for consigned luxury goods. It offers various resale product categories, including women’s, men’s, kids’, jewelry, and watches, as well as home and art products. The company was founded in 2011 and is headquartered in San Francisco, California.

Fluidigm

Series D in 2005
Fluidigm Corporation develops and distributes systems based on the properties of integrated fluidic circuits to control precisely fluids on a nano volume scale. The company's product line includes the TOPAZ system, which is used for protein crystallization; and the BioMark system, which is used for genetic analysis. Fluidigm Corporation was founded as Mycometrix Corporation in 1999 and was renamed as Fluidigm Corporation in 2001. The company is based in San Francisco, California.

Avedro

Series E in 2015
Medical device and pharmaceutical company advancing the science and technology of corneal cross-linking

Cape Clear Software

Series D in 2006
Cape Clear Software, Inc. provides services-oriented architecture (SOA) and enterprise service bus (ESB) technology. Its products include Server, a runtime engine that supports service hosting, of BPEL, Java, assembly, and database services; and multiple transports out-of-the-box; Studio, an Eclipse-based tools environment for the development of SOA-based and on-demand applications; and SOA Assembly for service implementation, manipulation of message parts, and handling of error conditions, as well as application of routing, splitting, and load-balancing rules.

Doximity

Series A in 2011
Founded in 2011, Doximity connects physicians and clinicians to make them more successful and productive. It is the largest professional medical network with over 70 percent of all U.S. physicians as members. The network enables medical professionals to communicate with colleagues and patients, and to share their perspectives on the latest health care trends and research. Doximity is based in San Francisco and was created by the founders of Epocrates and Rock Health. To learn more, visit www.doximity.com

Participate Systems

Series A in 1999
Participate Systems provides outsourced online sales and customer support community solutions. The platform offers self-help solutions, software and management services, monthly and quarterly reports, and operating plans.

Cape Clear Software

Series E in 2007
Cape Clear Software, Inc. provides services-oriented architecture (SOA) and enterprise service bus (ESB) technology. Its products include Server, a runtime engine that supports service hosting, of BPEL, Java, assembly, and database services; and multiple transports out-of-the-box; Studio, an Eclipse-based tools environment for the development of SOA-based and on-demand applications; and SOA Assembly for service implementation, manipulation of message parts, and handling of error conditions, as well as application of routing, splitting, and load-balancing rules.

Lombardi Software

Series C in 2006
A suite of business process management software and services in the united states

IntraLase Corporation

Venture Round in 2000
IntraLase Corporation is a leader in the first step of LASIK surgery, the most common means of surgical vision correction. They design, develop and market a laser, related software and disposable devices used to create a cut of tissue across the cornea of a patient’s eye, or a corneal flap, which is the first step in LASIK surgery. Their advanced laser technology improves the safety, precision and visual acuity of LASIK surgery by providing a computer-controlled laser solution as an alternative to the traditional method of creating the corneal flap using a hand-held mechanical, metal-bladed device called a microkeratome. They believe their product offering will become the new standard of care for corneal flap creation. As of April 2, 2007, IntraLase Corp. was acquired by Advanced Medical Optics Inc.

Nereus Pharmaceuticals

Series D in 2007
Nereus Pharmaceuticals, Inc. engages in the discovery and development of therapeutics for the treatment of oncology, infectious diseases, and inflammation. The company uses its marine microbiology technologies for the discovery and development of drug candidates. Its oncology drug candidates include NPI-2358, a tumor vascular disrupting agent for the treatment of solid tumors; and NPI-0052, a proteasome inhibitor for the treatment of solid tumors, lymphomas, and multiple myeloma. The company was founded in 1998 and is based in San Diego, California.

Obalon Therapeutics

Series C in 2012
Obalon is an engineering-driven medical technology company with a singular focus on innovative, high-quality gastric balloon technology. Located in San Diego, California, the technical team at Obalon has a long history of working closely with leading clinicians to develop innovative medical products that revolutionize the treatment of chronic disease. As a company, they believe in the fundamental value of imagination and invention, combined with rigorous testing and analysis, to ensure the highest levels of safety and performance. The result is a user-focused approach that deploys the power of advanced technological thinking to support clinical treatment objectives. It was founded in 2008.

Alvine Pharmaceuticals

Series A in 2009
Alvine Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing therapeutics for autoimmune/gastrointestinal diseases. Alvine's lead product candidate, ALV003, is a combination protease engineered to digest gluten. It is being developed to treat patients with celiac disease.

Bivio Networks

Series A in 2000
Founded in 2000, Bivio Networks is dedicated to providing leading networking products that enable government agencies and service providers to control, monitor, and secure critical network infrastructure. A leader in cyber intelligence, cyber security and network control solutions, Bivio has deployed its products in a wide range of solutions. Bivio’s global customer base includes leading intelligence agencies, military organizations and service providers. Bivio is privately-held and is headquartered in the San Francisco Bay Area with office locations worldwide. Specialties Cyber Security, Cyber Intelligence, Deep Packet Inspection (DPI) Networking Systems, Mass Metadata Extraction and Analysis, Data Retention System, Cyber Investigation, network probe

Totango

Series C in 2016
Totango, Inc. develops an enterprise grade customer success platform that allows users to connect their customers’ data, monitor health changes, and engage their customers. The company offers Customer Success Centre, a solution for customer engagement; Zoe, a solution for enterprise impact; and DNA-CX, a solution for multidimensional customer context in real-time. Its solutions include voice of the customer, customer onboarding, customer adoption, customer renewal, and customer escalation. The company was founded in 2010 and is based in Redwood City, California. Totango, Inc. operates as a subsidiary of Totango Ltd.

Invuity

Venture Round in 2012
Invuity, Inc. develops visualization products for the less invasive surgical field applications. It offers BriteField Port System that provides illumination and visualization during minimally invasive procedures; and BriteField McCulloch retractor, which allows physicians to achieve visualization during surgery while using traditional techniques. Invuity, Inc. was formerly known as Spotlight Surgical Inc. The company was founded in 2004 and is headquartered in San Francisco, California.

GoCheck

Series B in 2019
Gobiquity, Inc. provides prescribed mobile health applications for the early detection and prevention of health disorders and chronic diseases. It offers GoCheck Kids, a smartphone app that detects amblyopia risk factors and meets the American Association for Pediatric Ophthalmology and Strabismus guidelines for vision screening in children. Gobiquity, Inc. was formerly known as ICHECK Health Connection, Inc. The company was founded in 2010 and is based in Aliso Viejo, California.